Groundbreaking Progress in Obesity Treatment: NeuroBo Pharmaceuticals Receives FDA Clearance for Clinical Trial of DA-1726. In a significant milestone for obesity treatment, NeuroBo Pharmaceuticals, a leading pharmaceutical company, has received FDA clearance to commence a Phase 1 clinical trial for its new drug candidate, DA-1726. This marks a critical advancement in the medical field, with potential far-reaching implicati...
$ニューロボ・ファーマシューティカルズ(NRBO.US)$NeuroBo Pharmaceuticals Receives First Site IRB Approval For Its Phase 1 Clinical Trial Evaluating DA-1726 For Treatment Of Obesity
10
報告
Jaguar8 :
And of course they will buy this one even if it’s just Phase 1 which has not even started
ニューロボ・ファーマシューティカルズに関するコメント
Leading Medical Company Receives FDA Clearance For Obesity Drug Candidate
In a significant milestone for obesity treatment, NeuroBo Pharmaceuticals, a leading pharmaceutical company, has received FDA clearance to commence a Phase 1 clinical trial for its new drug candidate, DA-1726. This marks a critical advancement in the medical field, with potential far-reaching implicati...
volume is too light...good bye
pattern chart looks like back up
back up
nice move
News another weight loss drug! Hehehe
What's the move...
time to load up
drop more = load up more
see fruits on monday
まだコメントはありません